Expert Recommendations in Relapsed/Refractory Multiple Myeloma

In this on demand webcast, expert faculty discuss best practices in treating patients
with relapsed/refractory multiple myeloma. 

Myeloma News

Keep up to date on the latest multiple myeloma news and information.

Myeloma News

Recent Publications

An automated workflow based on data independent acquisition for practical and high-throughput personalized assay development and minimal residual disease monitoring in multiple myeloma patients

Clin Chem Lab Med. 2024 Jun 17. doi: 10.1515/cclm-2024-0306. Online ahead of print. ABSTRACT OBJECTIVES: Minimal residual disease (MRD) status in multiple myeloma (MM) is an important prognostic biomarker. Personalized blood-based targeted mass spectrometry detecting M-proteins (MS-MRD) was shown...

Adipocytes and metabolism: Contributions to multiple myeloma

J Bone Oncol. 2024 May 22;46:100609. doi: 10.1016/j.jbo.2024.100609. eCollection 2024 Jun. ABSTRACT Obesity contributes to many cancers, including breast cancer and multiple myeloma, two cancers that often colonize the bone marrow (BM). Obesity often causes metabolic disease, but at the cellular...